Immuneering Corp’s filing revealed that its Director BERMAN ANN E acquired Company’s shares for reported $0.14 million on Sep 23 ’25. In the deal valued at $9.72 per share,14,000 shares were bought.
Then, HAUSMAN DIANA bought 3,000 shares, generating $10,874 in total proceeds. Upon buying the shares at $3.62, the Director now owns 3,000 shares.
Before that, HAUSMAN DIANA bought 2,500 shares. Immuneering Corp shares valued at $8,989 were divested by the Director at a price of $3.60 per share. As a result of the transaction, HAUSMAN DIANA now holds 2,500 shares, worth roughly $21475.0.
Morgan Stanley downgraded its Immuneering Corp [IMRX] rating to an Underweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in mid March has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Jefferies revised its rating on March 15, 2024. It rated IMRX as “a Hold” which previously was an “a Buy”.
Price Performance Review of IMRX
On Tuesday, Immuneering Corp [NASDAQ:IMRX] saw its stock fall -1.60% to $8.59. Over the last five days, the stock has gained 3.37%. Immuneering Corp shares have risen nearly 254.96% since the year began. Nevertheless, the stocks have risen 290.45% over the past one year. While a 52-week high of $10.08 was reached on 09/22/25, a 52-week low of $1.10 was recorded on 05/12/25.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 8.11, which if violated will result in even more drops to 7.63. On the upside, there is a resistance level at 9.36. A further resistance level may holdings at 10.13.
How much short interest is there in Immuneering Corp?
A steep rise in short interest was recorded in Immuneering Corp stocks on 2025-08-29, growing by 0.27 million shares to a total of 1.83 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 1.56 million shares. There was a rise of 14.99%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 01, 2023 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
